Sagimet Biosciences Inc. (SGMT) income statement
SGMTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.08−0.54 (-5.61%)
Close on Nov 20, 2026Market cap $564.40MP/E –Yield –
Sagimet Biosciences Inc. financial ratios
See a number that looks wrong?